Results 241 to 250 of about 125,101 (330)
ABSTRACT Background Cutaneous squamous cell carcinoma (cSCC) is one of the most common nonmelanoma skin cancers, with increasing incidence globally. Beta genus human papillomaviruses (β‐HPVs), particularly in immunocompromised individuals, have been implicated in the development of cSCC. However, the strength of association between β‐HPV seropositivity
Shweh Fern Loo +3 more
wiley +1 more source
Vaping Troubles: Exploring the Link Between E-Cigarettes and Oral Lesions in India's Urban Youth.
Sekar G +6 more
europepmc +1 more source
Access to E-Cigarettes Is Easy in a Regional Area in Australia: A Qualitative Study to Explore Young People's Views on Vaping. [PDF]
Chandra R +3 more
europepmc +1 more source
Conventional Cigarette and E-Cigarette Smoking among School Personnel in Shanghai, China: Prevalence and Determinants [PDF]
Jingfen Zhu +6 more
openalex +1 more source
New Biologic and Small Molecule Therapies for Hidradenitis Suppurativa
ABSTRACT Hidradenitis suppurativa (HS) is an inflammatory skin disease that has historically been underdiagnosed and, until recently, under‐researched. Furthermore, the pathophysiology of HS is complex, and not fully understood. Just three biologic medications—adalimumab (anti‐TNF‐α), secukinumab (anti‐IL17A) and bimekizumab (anti‐IL17A/F) are licensed
Emily Pender +2 more
wiley +1 more source
Knowledge and awareness of E-Cigarettes among 18-24 years young adult's in Chennai - A pilot E-Survey. [PDF]
Indumathi KP +5 more
europepmc +1 more source
Public Health England prematurely endorses e-cigarettes [PDF]
Greenberg, A, Jose, RJ
core +1 more source
ABSTRACT This study explored the therapeutic efficacy of oxymatrine (OMT, C15H24N2O2) in a murine model of cigarette smoke (CS)‐induced chronic obstructive pulmonary disease (COPD) and elucidated its underlying mechanisms. A COPD model was established in mice through prolonged exposure to CS, followed by intraperitoneal administration of OMT (50 mg/kg)
Shuang Zhou, Ju‐Xiang Zhu, Jing Li
wiley +1 more source

